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Objective: Hydrogen sulﬁde (H2S), the third gasotransmitter together with NO and CO, is emerging as a
regulator of inﬂammation. To test if it might offer therapeutic value in the treatment of osteoarthritis
(OA) we evaluated the effects of two exogenous sources of H2S, NaSH and GYY4137, on inﬂammation and
catabolic markers that characterize OA.
Method: Human chondrocytes (CHs) were isolated from OA tissue. Cells were stimulated with a pro-
inﬂammatory cytokine (interleukin-1b, IL1b, 5 ng/ml) and the ability of the two H2S sources to
ameliorate its effects on the cells was tested. Nitric oxide (NO) production was quantiﬁed through the
Griess reaction. Protein levels of inducible NO synthase (NOS2) and matrix metalloproteinase 13
(MMP13) were visualized through immunocytochemistry (ICC). Relative mRNA expression was quanti-
ﬁed with qRT-PCR. Prostaglandin-2 (PGE-2), interleukin 6 (IL6) and MMP13 levels were measured with
speciﬁc EIAs. NFkB nuclear translocation was visualized with immunoﬂuorescence.
Results: Both H2S sources led to signiﬁcant reductions in NO, PGE-2, IL6 and MMP13 released by the cells
and at the protein level. This was achieved by downregulation of relevant genes involved in the synthesis
routes of these molecules, namely NOS2, cyclooxigenase-2 (COX2), prostaglandin E synthase (PTGES), IL6
and MMP13. NFkB nuclear translocation was also reduced.
Conclusion: NaSH and GYY4137 show anti-inﬂammatory and anti-catabolic properties when added to
IL1b activated osteoarthritic CHs. Supplementation with exogenous H2S sources can regulate the
expression of relevant genes in OA pathogenesis and progression, counteracting IL1b pro-inﬂammatory
signals that lead to cartilage destruction in part by reducing NFkB activation.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a degenerative joint pathology that results
in severe pain and loss of function. With a high prevalence among
the elderly population, it is one of the threemost common causes of
incapacitation in people younger than 601,2,3. OA is characterized by
a progressive loss of articular hyaline cartilage in the joints and
although its complete etiology is not known, it is generally accepted
that OA is caused by a deregulation of the catabolic and anabolic
processes that regulate cartilage matrix synthesis. Chondrocyteso: F.J. Blanco, Rheumatology
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as.es (E.F. Burguera), angela.
na.silva.magalhaes@sergas.es
@sergas.es (F.J. Blanco).
ternational. Published by Elsevier L(CHs), the only cell type present in cartilage, are responsible for
producing and maintaining the extracellular matrix (ECM) which,
normally, has a very low turnover rate. Loss of this equilibrium is
not the result of a single mechanism but of a complex interplay
between abnormal mechanical stresses, increased amounts of
proinﬂammatory cytokines and/or other insults.
OA has not traditionally been considered an inﬂammatory dis-
ease4, but many studies conﬁrm the implication of several pro-
inﬂammatory mediators, such as interleukin-1b (IL1b) and tumor
necrosis factor-a (TNF-a), in the progression of OA5. For instance,
elevated IL1b levels are found in the synovial ﬂuid of OA patients
and IL1b gene expression is upregulated in OA tissue. Additionally,
IL1b activates the synthesis and release of matrix metal-
loproteinases (MMPs) leading to matrix breakdown6.
Nitric oxide (NO) has also been implicated in the pathophysi-
ology of OA. NO is produced from L-arginine by NO synthases. Threetd. All rights reserved.
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NO, nNOS and endothelial NO, eNOS) and the expression of the
third isoform, NOS2, is induced in cellular stress situations and by
IL1b and TNF-a. At normal physiological concentrations NO in-
ﬂuences vascular tone, cell adhesion and vascular permeability7,
but, it can also exert potential toxic effects. Like IL1b, NO has been
shown to inhibit the synthesis of cartilage matrix components.
Excess production of NO is also linked to oxidative damage8.
In addition to the effects above, OA is also characterized by an
increase in PGEs production. PGEs are produced from arachidonic
acid in a cascade that involves cyclooxygenases 1 and 2 (COX1 and
COX2) which produce the intermediate form PGE H-2. PGE E syn-
thase (PTGES) converts PG (H)-2 to PGE E2 (PGE-2) downstream
of COX1 and COX29. OA cartilage produces high quantities of PGE-2
and PTGES is also upregulated, together with COX2, in IL1b and
TNF-a stimulated CHs5,9.
All these factors, probably synergistically10, contribute to the
increase in catabolic processes that lead to cartilage destruction in
OA.
Hydrogen sulﬁde (H2S) is emerging as a potential regulator of
inﬂammation and it might offer therapeutic value in the treatment
of OA. H2S has been traditionally classiﬁed as a toxic gas11 but in the
past 10e15 years, scientiﬁc opinion has changed as more reports on
its biological activity were published and it is now considered as a
biologically relevant molecule12,13. H2S is synthesized endoge-
nously in mammals from L-cysteine by at least two pyridoxal-50-
phosphate dependent enzymes, cystathionine b-synthase (CBS)
and cystathionine g-lyase (CTH) and to a lower extent by mercap-
topyruvate sulfurtransferase (MPST). Together with NO and CO, H2S
has been identiﬁed as a gasotransmitter14,15 and as such it can
permeate cellular membranes without a speciﬁc transporter. Low
(micromolar) levels of H2S have been found to be cytoprotective in
several disease models, whereas several inﬂammation animal
models have found increased endogenous levels of H2S (reviewed
in12,13). With respect to inﬂammatory rheumatic diseases, White-
man et al.16 were able to detect H2S in the synovial ﬂuid from pa-
tients with rheumatoid arthritis (RA) and OA as well as in plasma
from normal controls (37.6 mM). Levels from RA patients (62.41 mM)
were signiﬁcantly increased over those of the OA group (25.1 mM).
This group has also recently shown that human articular CHs and
mesenchymal progenitor cells synthesize CBS and CTH, and that
their expressionwas induced by various cytokines, including IL1b17.
Therefore, even though its role has not been clearly elucidated yet,
evidence suggests that H2S may have an important function in
inﬂammation and it might be of interest as a therapeutic agent in
diseases that have an inﬂammatory component, such as OA.
In this study, two exogenous sources of H2S, NaSH (a fast dis-
solving salt) and GYY4137 (as a slow releasing agent), were added
to cultures of IL1b-stimulated human articular CHs isolated from
osteoarthritic tissue. Concentrations of the H2S sources ranged
from 0.05 to 1 mM and their effects on several markers of inﬂam-
mation and cartilage degradation were investigated. Also, since
activation of nuclear factor-kB (NFkB) is directly responsible for the
upregulation of several proinﬂammatory cytokines and enzymes,
including NOS2, COX2 and IL618,19, this signaling route was inves-
tigated as a possible mechanism of action for H2S.
Methods
Materials
Dulbecco's Modiﬁed Eagle Medium (DMEM), fetal bovine serum
(FBS) and Penicillin/Streptomycin (P/S) were from Gibco (Gibco,
Madrid, Spain). Culture ﬂasks and other disposable plastic were
purchased from BD (BD Bioscience, Madrid, Spain). Sodiumhydrosulﬁde (NaSH), sodium nitrite, human recombinant inter-
leukin-1b (IL1b), trypsin and collagenase were purchased from
SigmaeAldrich (SigmaeAldrich Química S.A, Madrid Spain).
GYY4137 (Morpholin-4-ium 4 methoxyphenyl(morpholino phos-
phinodithioate)) was purchased from Santa Cruz Biotechnology,
Heidelberg, Germany. AlamarBlue®was purchased from Invitrogen
S.A., Barcelona, Spain. The Griess reagent was from Enzo Life Sci-
ence, Madrid, Spain. The PGE-2 EIA was purchased from GE
Healthcare, Barcelona, Spain and the ELISAs for matrix
metalloproteinase-13 (MMP13), and interleukin-6 (IL6) were pur-
chased from R&D systems (Madrid, Spain). Antibodies for NOS2,
MMP13 and NFkB p65 were from Abcam (Abcam plc, Cambridge,
UK), Thermo Scientiﬁc (Cienytech, A Coru~na, Spain) and Santa Cruz
Biotechnology, respectively. Reagents for immunocytochemistry
(ICC) were from Dako (Dako, Barcelona, Spain) and reagents for
molecular biology were from Invitrogen (Invitrogen S.A. Barcelona,
Spain), unless otherwise stated.
Tissue selection and cell culture
Osteoarthritic cartilage donors were patients of the Orthopedic
Service of the University Hospital A Coru~na (CHUAC) that had knee
or hip replacement surgery (seven men and six women, age
77.5 ± 10.0 years old). The local ethics committee approved the
study and written informed consent was obtained from all the
patients. CHs were isolated by sequential enzymatic digestion from
human articular cartilage as described previously20. Brieﬂy, carti-
lage sections were washed with saline and minced into small
pieces. This was then incubated with trypsin at 37 C for 10 min,
followed by 12e16 h incubationwith type IV clostridial collagenase
(2 mg/ml) in DMEM with 5% FBS and 1% P/S. Isolated cells were
centrifuged and re-suspended in expansion medium (DMEM con-
taining 10% FBS and 1% P/S) and allowed to grow until pre-
conﬂuent at 37 C in a humidiﬁed incubator with 5% CO2. The
cells used for the experiments were routinely checked for pro-
duction of collagen type II and aggrecan to ensure they maintained
a chondrocytic phenotype.
Cell stimulation and treatment experiments
Only cells from passage two were used. For all experiments cells
were incubated in expansion medium during 24 h for adherence,
then the medium was changed to depleted medium (DMEM con-
taining 0.5% FBS and 1% P/S) with the different concentrations,
0 (Basal), 100, 200, 500 or 1,000 mM of one of the sulﬁde sources
(NaSH or GYY4137) and with or without IL-1b (5 ng/ml), for an
additional incubation time of either 24 h (cell viability) or 48 h (rest
of the experiments).
Cell viability assay
The effect of the sulﬁde-releasing compounds on CH viability
was determined with AlamarBlue® cell viability reagent following
manufacturer instructions. Cells were seeded (5$104/well, 96 well
plates) and treated as described above. AlamarBlue® was added to
the cells in a volume equivalent to 10% of the total volume.
Reduction of AlamarBlue® was measured with a spectrophotom-
eter (Nanoquant Inﬁnite M200, Tecan Iberica Instrumentacion S.L
Barcelona, Spain) at 570 nm and with 600 nm as a reference, after
4 h of incubation.
NO production assay
The Griess reaction was used to determine the effects of NaSH
and GYY4137 on NO production in IL1b-stimulated CHs21. CHs were
Table I
Primers and probes used for the qRT-PCR experiments
Gene RefSeq (mRNA) Primers sequences Position Probe n# Amplicon length (bp)
HPRT1 NM_000194.2 50-tgatagatccattcctatgactgtaga-30
50-caagacattctttccagttaaagttg-30
434e460
535e560
22 127
TBP NM_003194.4 50-gcccatagtgatctttgcagt-30
50-cgctggaactcgtctcacta-30
104e124
223e242
67 139
INOS NM_000625.4 50-gctgccaagctgaaattga-30
50-gatagcgcttctggctcttg-30
3,562e3,580
3,615e3,634
68 73
PTGES NM_004878.4 50-ctgggatgacaggcatgaat-30
50-gactcacatgggagcctttt-30
1,237e1,256
1,286e1,305
83 69
COX2 NM_000963.2 50-cttcacgcatcagtttttcaag-30
50-tcaccgtaaatatgatttaagtccac-30
707e728
777e802
23 96
IL-6 NM_000600.3 50-gctgagtacaaaagtcctgatcca-30
50-ctgcagccactggttctgt-30
548e571
659e677
40 130
MMP13 NM_002427.2 50-ccagtctccgaggagaaaca-30
50-aaaaacagctccgcatcaac-30
909e928
974e993
73 85
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Culture supernatants (50 ml) were collected for nitrite measure-
ments and mixed with 50 ml of Griess reagent. NO formation was
detected by nitrite accumulation using sodium nitrite as standard.
Optical density was measured at 570 nm in a Nanoquant Inﬁnite
M200 spectrophotometer (Tecan).NOS2 and MMP13 ICC
The effect of NaSH and GYY4137 on the accumulation of NOS2
and MMP13 proteins in IL1b-stimulated CHs was measured
through ICC. Cells were seeded (3$104/well, 8 well chamber
slides), treated as described above and then ﬁxed in acetone at
4 C for 10 min. The endogenous peroxidase activity was blocked
with Dako Real™ peroxidase blocking solution during 10 min at
room temperature. Cells were washed with phosphate buffer so-
lution (PBS) and incubated with either rabbit-antihuman poly-
clonal NOS2 antibody or mouse-antihuman MMP13 monoclonal
antibody. The rabbit/mouse peroxidase/DAB DAKO REAL™ EnVi-
sion™ detection kit was used to determine antigeneantibody
interactions. Slides were dehydrated in graded alcohol, cleared in
xylene and mounted in DePeX (Gurr®, VWR International Eurolab
S.L., Barcelona, Spain). A negative control was included by omit-
ting the primary antibody in one of the wells. Slides were then
visualized in an Olympus Dx61 optical microscope (Olympus
Espa~na S.A.U., Barcelona, Spain).NFkB immunoﬂuorescence
For the NFkB immunoﬂuorescence assay cells were seeded
(3$104/well, 8 well chamber slides) and treated as described
above, but for only 45 min, to be able to detect NFkB trans-
location to the cells nuclei and then ﬁxed in paraformaldehyde at
4 C for 10 min. Cells were then treated with 3% Triton-X for
5 min, washed subsequently with water and PBS. Cell were
incubated with the antibody for 3 h in the dark, counterstained
with DAPI for 30 min and mounted with Glycergel mounting
medium.Table II
CH viability, as measuredwith AlamarBlue reagent. Results are mean and 95% conﬁdence i
in duplicate. A Kruskal Wallis rank sum test was performed; for NaSH, P ¼ 0.80 and for
%Viability
Mean (Ll 95% CI,
ul 95% CI), n ¼ 3
Basal IL1b H2S compound concen
50 1
NaSH 100.0 (46.3, 153.7) 106.5 (34.5, 181.4) 107.2 (54.0, 156.7) 1
GYY4137 100.0 (53.7, 146.3) 106.5 (45.7, 170.8) 98.9 (50.4, 150.5)PGE-2, IL6 and MMP13 ELISA assays
The effect of the addition of the H2S sources on PGE-2, MMP13
and IL6 production in IL1bestimulated CHs was quantiﬁed on cell
supernatants using speciﬁc enzyme immunoassays, following their
manufacturer instructions. Cells were seeded (5$104/well, 96 well
plates) and treated as described above. The calibration curves for
PGE-2 EIA, the MMP13 ELISA and the IL6 ELISA spanned from 50 to
6,400 ng/ml, from 33 to 4,200 pg/ml and from 9.4 to 1,200 pg/ml,
respectively. Samples were diluted accordingly.
qRT-PCR analyses
The effect of NaSH and GYY4137 on the expression of the genes
included inTable I in IL1b-stimulated CHswas quantiﬁed using qRT-
PCR. Cells were seeded (3$105/well, 12 well plates) and treated as
described above. Total RNA was isolated using Trizol® Reagent,
following the manufacturer protocol. RNA concentration was
quantiﬁed at 260 nm using a NanoDrop™ spectrophotometer
(Thermo Scientiﬁc, Madrid, Spain). The A260/A280 ratio was
calculated to verify quality and purity. Integrity of RNAwas veriﬁed
with an Agilent 2100 Bioanalyzer (Agilent Technologies Spain S.L.,
Madrid, Spain). Total RNA was treated with DNase enzyme (Fer-
mentas, Fisher Scientiﬁc, Madrid, Spain) to degrade residual
genomic DNA. Complementary DNAwas synthesized from 0.5 mg of
total RNAusing SuperScript®VILO™MasterMix in a total volume of
10 ml in a Thermocycler (Gene Amp PCR System 9700, Applied Bio-
systems,Madrid, Spain). qRT-PCRexperimentswere performed on a
LightCycler1 480 Instrument (Roche, Mannheim, Germany) using
Taqman probes (Universal Probe Library set, Roche). Primers and
probe assays were designed using Roche Assay Design Center
available atwww.universalprobelibrary.com.Designedprobe assays
are included in Table I. PCR reactions consisted of a pre-incubation
(95 C, 10 min) (up to) 45 cycles of ampliﬁcation including incuba-
tion (95 C 10 s), extension (60 C, 30 s) and cooling (72 C, 1 s) and
ﬁnal cooling ramp (40 C, 20 s). HPRT1 (Hypoxanthine-guanine
phosphoribosyltransferase) and TBP (TATA box binding protein)
genes were used as the reference genes. These genes were previ-
ously selected from a reference gene panel using GeNorm software.ntervals (Lower limit, ll, upper limit ul) of n¼ 3 independent experiments performed
GYY4137, P ¼ 0.78
tration (mM)
00 200 500 1,000
03.4 (43.8, 161.2) 104.4 (43.6, 163.1) 100.0 (42.7, 157.7) 98.2 (41.3, 156,1)
94.9 (51.0, 143.2) 93.7 (48.1, 143.5) 98.6 (54.1, 143.8) 99.4 (50.2, 149.4)
E.F. Burguera et al. / Osteoarthritis and Cartilage 22 (2014) 1026e1035 1029Relative levels of expressionwere calculated using qBaseþ software
(www.BioGazelle.com). Data were normalized against the mean
value obtained in unstimulated cells (Basal), which was normalized
to 1, and were expressed as relative expression levels.
Statistical analyses
All qRT-PCR experiments were performed with cells from n  3
biological replicates and duplicate technical repeats. Relative
expression values were calculated with qBase þ software and are
expressed as the geometric mean and 95% lower and upper limit
conﬁdence intervals. Statistical analysis (one-way ANOVA followed
by a post-hoc test) of these results was done with qBase þ software
too. For the rest of the experiments, results are expressed as meanFig. 1. Addition of NaSH (A, C) and GYY4137 (B, D) to IL1b-stimulated CHs reduced nitrite ac
by qRT-PCR (C and D) and NOS2 protein accumulation, by ICC (EeM). Values are mean and 9
and B, KruskaleWallis rank sum test was performed followed by multiple comparisons.
comparisons test. *P < 0.0001 (cf. Basal group); #P < 0.0001 (cf. IL1b stimulated group), ex
different concentrations of NaSH (HeJ) and GYY4137 (KeM). A negative ICC control (withoutand 95% lower and upper limit conﬁdence intervals of at least three
biological replicates and duplicate technical repeats. Statistical
analyses were performed with R software (version 2.15.2)22. Data
were assayed with one-way ANOVA and a Tukey multiple com-
parisons test. In all cases, a P value lower than 0.05 was considered
signiﬁcant.Results
Cell viability
Reduction of AlamarBlue® values were normalized with respect
to the basal condition which was given an arbitrary value of 100%.cumulation, as measured through the Griess reaction (A and B), NOS2 gene expression,
5% CI (Lower limit, upper limit, n number in parenthesis, performed in duplicate). In A
In C and D, one way ANOVA was performed followed by a Tukey post-hoc multiple
cept for C where P ¼ 0.0001. ICC images include IL1b-stimulated CHs (G) treated with
primary antibody (E)), as well as unstimulated cells (F), were included for comparison.
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reduced the viability of the OA CHs (Table II).
Sulﬁde compounds reduce NO production by downregulating NOS2
gene expression
Basal production of NO (measured as nitrite) ranged from around
0.06 mMe12 mM (3.92 (1.64, 6.20), n ¼ 7, performed in duplicate).
Stimulation with IL1b (5 ng/ml) increased in production of NO to
values that ranged between 23 mMand 133 mM (79.85 (63.70, 96.00),
n ¼ 7, performed in duplicate) [Fig. 1(A) and (B)]. Addition of the
different concentrations of H2S compounds did not induce the for-
mation of NO by itself (results not shown). Both NaSH and GYY4137
induced a dose-dependent reduction on NO production in IL1b
stimulated cells, with values for 500 mM and 1,000 mM NaSH and
GYY4237 being signiﬁcantly lower [Fig. 1(A) and (B)].
NOS2 mRNA expression was quantiﬁed with qRT-PCR. Stimula-
tion with IL1b induced NOS2 mRNA expression and the addition of
H2S-releasing agents dose-dependently attenuated this increase,
however, none of the values were signiﬁcantly different from the
IL1b value. For both NaSH and GYY4137, 1,000 mM was the mostFig. 2. PGE E2 production in IL1b-stimulated CHs declined after treatment with different c
mRNA expression in the cells was also reduced due to the addition of NaSH (C, E) and GYY41
upper limit, n ¼ 3). Relative mRNA expression values were calculated, with respect to the
duplicate. One way ANOVA and post-hoc multiple comparisons tests were performed to iden
stimulated group); in D, *P ¼ 0.003 (cf. Basal group) and #P < 0.001 (cf. IL1b stimulated groueffective concentration in reducing NOS2mRNA expression [Fig.1(C)
and (D)]. Results obtained through the Griess reaction and those of
qRT-PCR were corroborated also by ICC [Fig. 1(E)e(M)]. In addition,
to ensure that these results were due to the H2S released from NaSH
and GYY4137, we performed these same experiments with decom-
posed NaSH and GYY4137 (stock solutions were left uncapped in a
chemical hood for 10 days). In this case, all effects were lost, no
reduction was observed in NO production or NOS2 relative expres-
sion from the IL1b-stimulated values (results not shown).
H2S compounds reduce PGE-2 levels by downregulating COX2 and
PTGES enzymes
PGE-2 basal level was 0.25 (0.13, 0.36) ng/ml (n ¼ 3) in the cells.
Stimulationwith IL1b led to an increase up to 64.7 (41.78, 87.66) ng/
ml PGE-2. Different concentrations of NaSH and GYY4137 were
added to the IL1b-stimulated cells to investigate their effect on
PGE-2 production [Fig. 2(A) and (B)]. All concentrations tested,
except for 1,000 mM NaSH and 50 mM GYY4137, resulted in a sig-
niﬁcant decrease from the IL1b-stimulated cells. When looking at
the mRNA expression of the main enzymes involved in PGE-2oncentrations of NaSH (A) and GYY4137 (B). Concurrently, COX2 (C, D) and PTGES (EeF)
37 (D, F). PGE-2 values, measured with a speciﬁc EIA are mean and 95% CI (Lower limit,
Basal condition with qBase þ software, n indicated in parenthesis and performed in
tify signiﬁcant differences. In AeC, *P < 0.001 (cf. Basal group) and #P < 0.001 (cf. IL1b
p) and in EeF, *P < 0.0001 (cf. Basal group) and #P < 0.0001 (cf. IL1b stimulated group).
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mRNA expression [Fig. 2(C) and (D)] from the IL1b-induced in-
crease. In particular, the IL1b-induced value was 97.5 (19.5, 487,9)
fold vs Basal and 1,000 mMNaSH and GYY4137 reduced this value to
12.0 (1.6, 89.13) and 7.6 (0.4, 142,1), respectively, n ¼ 4. Interleukin-
1b also induced an elevation of PTGESmRNA expression (68.5 (19.8,
236.7) vs Basal) and 1,000 mM NaSH and GYY4137 considerably
reduced this value to 16.3 (3.8, 69.2) and 31.7 (8.3, 120.7), respec-
tively, n ¼ 4 [Fig. 2(E) and (F)].
H2S compounds also reduce IL6 levels and mRNA expression
IL6 levels were increased due to stimulation with IL1b (184.3
(146.6, 222.1) ng/ml vs 106 (36, 176) pg/ml in the unstimulated
cells). Measured levels decreased in cells co-stimulated with IL1b
and NaSH or GYY4137. The best results were obtained for concen-
trations 1,000 mM NaSH (86.2 (65.2, 151.5) ng/ml) and 1,000 mM
GYY4137 (89.1 (57.13, 121.1) ng/ml) [Fig. 3(A) and (B)]. Similar re-
sults were obtained for the mRNA expression levels; IL6 expression
was also induced by IL1b (7,743 (3,250, 18,447)) and co-stimulation
with the H2S sources reduced it in a dose-dependent manner. In
this case, both 1,000 mM NaSH and GYY4137 were the best con-
centrations and their values were signiﬁcant reductions from the
IL1b value (616.0 (33.2, 11,430) and 543.3 (34.6, 8,540) vs Basal,
respectively) [Fig. 3(C) and (D)].
H2S compounds show anti-catabolic properties
We also looked at the effects of H2S compounds on MMP-13
production. Interleukin-1b increased MMP13 levels to 44.1 (26.7,
61.6) ng/ml (Basal level was 556 (438, 674) pg/ml, n ¼ 3, performed
in duplicate) that were subsequently reduced to 33.5 (22.1, 44.9)
ng/ml for 1,000 mMNaSH and 17.3 (9.9, 24.6) ng/ml for 1,000 mM for
GYY3147 [Fig. 4]. Also due to the IL1b addition, MMP13 mRNA
expression increased up to 48.4 (17.7, 132.2) (fold vs Basal) [Fig. 4(C)Fig. 3. Interleukin-6 levels (measured with a speciﬁc ELISA, A-B) and mRNA expression (by q
concentrations of NaSH (A, C) and GYY4137 (B, D). For the ELISA experiments, values are mean
PCR, values were calculated with qBase þ software, n ¼ 4 with duplicate technical repeats
except in B where a KruskaleWallis rank sum test followed by multiple comparisons was per
group); for B *P < 0.001 (cf. Basal group) and #P < 0.001 (cf. IL1b stimulated group).and (D)]. For both NaSH and GYY4137, 1,000 mM was the most
efﬁcacious concentration in reducing MMP13 expression (down to
12.2 (3.6, 42.0)) for NaSH, and 8.2 (1.68, 40.1) for GYY4137 [Fig. 4(C)
and (D)]. Also at the protein level in ICC, MMP13 levels were clearly
decreased by co-stimulationwith both H2S-sources [Fig. 4(E)e(M)].
H2S compounds reduce NFkB p65 translocation to the nucleus
In an attempt to elucidate the possible mechanism bywhich H2S
might be exerting the observed effects, an immunoﬂuorescence
assay was performed to visualize NFkB p65 nuclear translocation in
the cells. Results are included in Fig. 5. In the basal condition, p65
was located mostly in the cytoplasms of the cells [Fig. 5(A)]. Stim-
ulation with IL1b resulted in the translocation of p65 to the nuclei
of the cells, as can be clearly seen in Fig. 5(B). Co-stimulation with
the different concentrations of H2S compounds resulted in a
reduction in the ﬂuorescence intensity in the nuclei [Fig. 5(C)e(G),
for GYY4137 and Fig. 5(H)e(L) for NaSH], although p65 could still be
seen in the nuclei and the basal condition was not recovered.
Discussion
This paper evaluates the ability of two exogenous H2S sources as
antieinﬂammatory and antiecatabolic agents in human articular
CHs. Interleukin-1b was used as prototype pro-inﬂammatory
cytokine to reproduce the “OA-like effect” in the cells. As ex-
pected5,6, the stimulation of OA CHs with IL1b induced the pro-
duction of markers of inﬂammation and catabolic activity such as
NO, PGE-2, IL6 and MMP13.
NO is a multifunctional molecule that mediates various biolog-
ical processes and is a well-known mediator in OA. It has been
reported that OA CHs die by NO-induced apoptosis21, that OA CHs
produce NO spontaneously23 and that human articular CHs express
NOS2 when stimulated in culture24. Later studies reported that the
most direct effect of NO in CHs seemed to be the suppression ofRT-PCR, C, D) were both reduced in IL1b-stimulated CHs after treatment with different
and 95% CI (Lower limit, upper limit, n ¼ 3, with duplicate measurement). For the qRT-
. One way ANOVA was performed followed by a post-hoc multiple comparisons tests,
formed. For A, C and D *P < 0.0001 (cf. Basal group) and #P < 0.0001 (cf. IL1b stimulated
E.F. Burguera et al. / Osteoarthritis and Cartilage 22 (2014) 1026e10351032energy metabolism25, but it has also been suggested that NO can
inhibit matrix synthesis by CHs26. Our results show a dose-
dependent reduction of NO levels and the inducible synthesis
enzyme, NOS2, with both NaSH and GYY4137. Our GYY4137 results
are in line with those recently published for lipopolysaccharide
(LPS)-activated hCHs18 treated with this compound, but those of
NaSH contradict a recent publication27 in which its use led to an
increase in NO and NOS2 in rat vascular smooth muscle cells. Also,
another study described that NaSH had a biphasic effect and at high
concentrations (>200 mm) increased the synthesis of NO in a
macrophage cell line28. Some authors reported that H2S can react
directly with ROS and reactive nitrogen species (RNS)12,29,30 which
might account for part of the reduction they observed in NO, but inFig. 4. Addition of NaSH (A, C) and GYY4137 (B, D) to IL1b stimulated CHs resulted in reduce
expression by qRT-PCR (C and D), and in less MMP13 protein accumulation, by ICC (EeM). V
ANOVA and a post-hoc multiple comparisons test were performed to identify signiﬁcant
comparisons was done. ICC images include IL1b-stimulated CHs (G) treated with different
primary antibody (E)), as well as unstimulated cells (F), was included for comparison. For B
*P < 0.00467 (cf. Basal group) and #P < 0.00467 (cf. IL1b stimulated group).our case the NO decline is accompanied by a downregulation of the
NOS2 gene and a reduction in the NOS2 protein. Therefore the
reduction in NO cannot only be the result of a redox reaction and
our results in the present in vitro model suggest that the H2S
compounds can directly regulate the NOS2 gene.
The role of H2S in inﬂammatory signaling has not been eluci-
dated yet. Many reports attribute H2S both pro- and anti-
inﬂammatory properties depending on the pathology studied, the
experimental model used or the source of H2S13,31.
The effects of NaSH and GYY4137 on the release of pro- and anti-
inﬂammatory mediators in LPS-treated murine RAW264.7 macro-
phages were recently investigated28. GYY4137 inhibited LPS-
induced release of pro-inﬂammatory mediators IL1b, IL6, TNF-a,d MMP13 production, measured with a speciﬁc ELISA (A and B), reduced MMP13 gene
alues are mean and 95% CI (Lower limit, upper limit, n ¼ 3, with duplicates). One way
differences, except in A where a KruskaleWallis rank sum test followed by multiple
concentrations of NaSH (HeJ) and GYY4137 (KeM). A negative ICC control (without
eD *P < 0.0001 (cf. Basal group) and #P < 0.0001 (cf. IL1b stimulated group), and for A
Fig. 5. Immunoﬂuorescence images of NFkB p65 protein in IL1b stimulated CHs (45 min). In the basal condition (no stimulation) p65 can be seen mostly in the cells cytoplasms. IL1b
stimulation lead to p65 translocation to the nuclei and the different concentrations of GYY4137 (CeG) and NaSH (HeL) resulted in a slight reduction of the nuclear ﬂuorescence
intensity, although p65 can still be seen in the nuclei and the basal situation was not fully recovered.
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contrast, NaSH had a biphasic effect and at high concentrations
(>200 mm) increased the synthesis of IL1b, IL6, TNF-a, and PGE-2.
On the other hand, reductions in PGE-2 and COX2 levels were
also found in LPSeactivated normal human ﬁbroblast-like syno-
viocytes (hFLS) and hCHs18.
Our results show a dose-dependent reduction in COX2 for both
H2S sources. COX2 is considered the “inducible” COX isoform,
activated by many factors, and current anti-inﬂammatory therapy
for OA makes use of COX2 inhibitors. These unfortunately, have
other disadvantages, including an accompanying inhibition of
physiologic COX132. In the present results, COX2 inhibition was
achieved at the highest H2S-compound concentration used,
without signiﬁcantly affecting COX1 (results not shown). In addi-
tion, our results also show a reduction of PTGES gene expression
due to the H2S co-stimulation. PTGES was demonstrated as a key
enzyme in the regulation of PGE-2 production in cytokine stimu-
lated CHs from patients with OA9, suggesting that the terminal PG
synthase downstream of COX is important for deciding which PG is
synthesized, and that the induction of PTGES might be necessary
for substantial PGE-2 production by CHs in response to pro-
inﬂammatory stimuli. Therefore, the H2S-sources can regulate the
two most important enzymes implicated in PGE-2 production in
activated hCHs.
Furthermore, in our model, IL6 production was stimulated by
IL1b and the co-stimulation with H2S-releasing compounds both
downregulated IL6 gene mRNA expression and reduced IL6 levels
produced by the cells. Two different studies have recently showed
that NaSH could transiently block IL6 expression, ﬁrst in RA
ﬁbroblast-like synoviocytes33 and later in a CH cell line C-28/I234.
IL6 can show both pro-inﬂammatory and anti-inﬂammatory ef-
fects (since, by itself, it can induce the production of tissue in-
hibitor of metalloproteinase, TIMP, but not MMPs) but IL1-induced
IL6 is required for the inhibition of proteoglycan synthesis by IL1
in human articular cartilage35; also IL6 is synergistically respon-
sible for IL1einduced MMPs increases6 and IL6 or its receptor are
therapeutic targets for OA36. Therefore, the H2S-sources as used
here can further reduce inﬂammation by regulating IL6 geneexpression, resulting in lower free IL6 cytokine released by the
cells.
Collagenase 3 (MMP13) is the major type II collagen-
degrading collagenase. It is regulated by stress-, inﬂammation-
and differentiation-induced signals. Work by Goldring and col-
leagues recently reviewed10 has singled out MMP13 as the key
gene upon which many of the signaling pathways (i.e., NFkB, JNK
or p38 MAPK) and transcription factors (such as NFkB, HIF2a, Ihh,
or Runx2) involved at the different stages of OA converge. Most
of these regulatory factors directly or indirectly, impact on
MMP13 transcription and activity. In our model, 1,000 mM of the
two H2S-compounds used, reduced MMP13 below the IL1b-
induced levels at the mRNA and at the protein level also. There
are, to the best of our knowledge, no other reports available on
the effects of NaSH or GYY4137 on MMP13 activity on human
osteoarthritic CHs. However, it has been reported that NaSH
(20 min, 1 mM) upregulated the expression of the MMP3 gene in
RA-FLS, while MMP3 was not detected at the mRNA level in the
OA-FLS37. On the other hand, DAS, an oil-soluble organosulfur
compound extracted from garlic, reduced MMP13 synthesis in
IL1b-activated rabbit CHs38.
Additionally, the H2S compounds used in the present model
seem to reduce the translocation of NFkB to the CHs nuclei,
although not to prevent it completely. Activation of NFkB is directly
responsible for the upregulation of several proinﬂammatory cyto-
kines and enzymes, including NOS2, COX2 and IL618,19, so it is a
plausible mechanism of action for NaSH and GYY4137. Nevertheless
further studies are needed to conﬁrm H2S implication in the NFkB
signaling pathway and to investigate what other signaling routes
might be implicated.
Collectively, our results show that supplementation with exog-
enous H2S taps on important markers in OA and indicate that OA
cartilage might beneﬁt from the exogenous supplementation of
H2S. However, the current results obtained in vitro might not
translate to an in vivo situation, and this should be tested directly.
Nevertheless, current data should grant further study into the
implication of H2S, both exogenously added and/or endogenously
controlled, in OA as a potential therapeutic target.
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